Express Scripts announced an enhancement of its offer to acquire Caremark Rx. The Express Scripts offer is to acquire all outstanding shares of Caremark for $29.25 in cash and 0.426 shares of Express Scripts stock for each share of Caremark stock. The company will now pay an additional cash consideration of approximately 6% per annum on the $29.25 cash portion of Express Scripts' offer.
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.